Bladder cancer is one of the leading causes of death worldwide. The main immune
mechanisms which lead to bladder cancer development or treatment outcomes have yet to …

Context.—Since the publication of the previous World Health Organization (WHO)
Classification of Tumours on the Pathology and Genetics of Tumours of the Urinary System …

ABSTRACT Purpose: Prostatic carcinoma (Pca) at cystoprostatectomy is usually an
incidental finding with the majority thought to be clinically insignificant. Most studies have not …

OBJECTIVES: To evaluate the indications for early and deferred cystectomy and to report
the impact of this tailored approach on survival. DESIGN, SETTING, AND PARTICIPANTS …

Purpose: We report long-term followup data on patients with World Health Organization
(WHO) grade I bladder tumors, and determine whether histopathological subgrouping as …

PURPOSE: We determined whether pathological findings on restaging transurethral
resection predict early stage progression of T1 bladder cancer. MATERIALS AND …

Abstract The Genitourinary Pathology Society (GUPS) undertook a critical review of the
recent advances in bladder neoplasia with a focus on issues relevant to the practicing …

Study Type–Prognosis (case series) Level of Evidence 4 OBJECTIVE To assess the impact
of patient age on outcomes after radical nephroureterectomy (RNU) for upper tract urothelial …

Objective Neutrophil-to-lymphocyte ratio (NLR) predicts advanced stage disease and
decreased survival in patients undergoing radical cystectomy for urothelial carcinoma of the …

Cytological examination of urine is the most widely used noninvasive pathologic screen for
bladder urothelial carcinoma (BLCA); however, inadequate diagnostic accuracy remains a …